Journal of Clinical and Scientific Research (Jan 2022)

COVID-19 to mucormycosis

  • Tejaswini Kasinede,
  • Srilakshmi Gaddam,
  • Joy Blessy Lois Ts,
  • K Dinesh Kumar,
  • J Rani,
  • A Naga Soumya,
  • Lakshmi Aishwarya Pavuluri,
  • M Murali,
  • Rapur Ram,
  • V Siva Kumar

DOI
https://doi.org/10.4103/0028-3886.355151
Journal volume & issue
Vol. 11, no. 5
pp. 41 – 44

Abstract

Read online

A 54-year-old man with hypertension, end-stage renal disease (ESRD) who was receiving thrice-weekly haemodialysis for the past 3 years, developed breathlessness after a session of haemodialysis. Oxygen saturation by pulse oximetry (SpO2) was 88% and he was admitted for evaluation. Nasopharyngeal swab real time-polymerase chain reaction (RT-PCR) had tested positive for SARS-CoV-2. He was started on intravenous azithromycin, dexamethasone 8 mg, and subcutaneous heparin. On the 8th day after admission, he had painful swelling, redness and watering of the left eye. Within hours, he also complained swelling of the left half of the face, diminished vision and reduced eye movements of the left eye. Magnetic resonance imaging (MRI) and magnetic resonance angiography of the brain revealed left orbital cellulitis. angioinvasive fungal sinusitis. Laboratory testing confirmed the diagnosis. The patient was treated with intravenous ammphotericin B and surgery.

Keywords